Q16537
PR
Gene name |
PPP2R5E |
Protein name |
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform |
Names |
PP2A B subunit isoform B'-epsilon, PP2A B subunit isoform B56-epsilon, PP2A B subunit isoform PR61-epsilon, PP2A B subunit isoform R5-epsilon |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:5529 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q16537
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q16537-F1 | Predicted | AlphaFoldDB |
172 variants for Q16537
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
CA390113666 rs1468595054 |
3 | S>A | No |
ClinGen TOPMed |
|
|
rs373172813 CA262469082 |
3 | S>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
|
CA262469081 rs1028023177 |
6 | T>A | No |
ClinGen TOPMed |
|
|
rs746635308 CA7218504 |
7 | T>P | No |
ClinGen ExAC gnomAD |
|
|
CA390113594 rs1470907942 |
9 | P>L | No |
ClinGen TOPMed |
|
| rs753518402 | 9 | P>missing | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs779891878 CA7218503 |
9 | P>A | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs758176830 CA7218501 |
10 | S>L | No |
ClinGen ExAC gnomAD |
|
|
CA262469080 rs79843138 |
11 | V>G | No |
ClinGen Ensembl |
|
| TCGA novel | 12 | D>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs964950280 CA262469079 |
14 | V>A | No |
ClinGen TOPMed |
|
|
rs111360318 CA390113473 |
19 | R>W | No |
ClinGen gnomAD |
|
|
rs753998212 CA7218497 |
22 | V>I | No |
ClinGen ExAC gnomAD |
|
|
rs1367516565 CA390113391 |
25 | A>P | No |
ClinGen gnomAD |
|
|
CA262469076 rs866128704 |
28 | K>R | No |
ClinGen Ensembl |
|
|
CA7218496 rs764048030 |
29 | R>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA7218494 rs775838926 |
33 | S>F | No |
ClinGen ExAC gnomAD |
|
|
rs535219008 CA7218493 |
36 | F>L | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA7218492 rs759988254 |
38 | S>P | No |
ClinGen ExAC gnomAD |
|
|
rs774544013 CA7218491 |
39 | Q>E | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA390113211 rs1260833884 |
39 | Q>R | No |
ClinGen gnomAD |
|
|
rs146814235 CA262469074 |
41 | K>R | No |
ClinGen ESP |
|
|
rs144779635 CA7218489 |
43 | I>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA390113168 rs1266064094 |
43 | I>V | No |
ClinGen gnomAD |
|
|
rs776246979 CA7218488 |
46 | T>A | No |
ClinGen ExAC gnomAD |
|
|
rs566526940 CA262469073 |
47 | P>S | No |
ClinGen 1000Genomes gnomAD |
|
|
rs1335995706 CA390113094 |
49 | P>L | No |
ClinGen TOPMed |
|
| TCGA novel | 49 | P>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA262469072 rs1042484228 |
50 | L>P | No |
ClinGen TOPMed |
|
|
rs200507102 CA390111561 |
53 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA390113056 rs1477269632 |
53 | D>N | No |
ClinGen gnomAD |
|
| TCGA novel | 53 | D>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA390111567 rs1399471875 |
53 | D>V | No |
ClinGen gnomAD |
|
|
COSM956874 rs777853785 CA7218460 |
54 | V>I | Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
|
CA262459094 rs376032244 |
58 | E>G | No |
ClinGen ESP |
|
| TCGA novel | 63 | F>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA262459092 rs900434873 |
77 | M>T | No |
ClinGen TOPMed |
|
|
rs903965809 CA262459093 |
77 | M>V | No |
ClinGen TOPMed |
|
|
rs752850551 CA7218458 |
78 | D>G | No |
ClinGen ExAC gnomAD |
|
|
rs781401535 CA7218457 |
79 | T>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
rs1594892048 CA390111136 |
80 | L>P | No |
ClinGen Ensembl |
|
|
rs1342679678 CA390111101 |
83 | L>V | No |
ClinGen TOPMed gnomAD |
|
|
CA262459091 rs1045456091 |
85 | M>T | No |
ClinGen TOPMed |
|
|
CA390110986 rs1238132393 |
90 | R>C | No |
ClinGen gnomAD |
|
|
CA390110975 rs1204903966 |
92 | T>A | No |
ClinGen gnomAD |
|
|
rs751728433 CA7218455 |
97 | V>M | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 98 | D>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 98 | D>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1274479082 CA390110926 |
99 | Y>C | No |
ClinGen TOPMed gnomAD |
|
|
rs763242209 CA7218453 |
99 | Y>H | No |
ClinGen ExAC gnomAD |
|
|
CA390110922 rs1214604524 |
100 | I>V | No |
ClinGen TOPMed |
|
|
rs78672940 CA262459090 |
107 | L>F | No |
ClinGen Ensembl |
|
|
CA390110851 rs1281294574 |
110 | Q>P | No |
ClinGen TOPMed gnomAD |
|
|
rs778408710 CA262459089 |
111 | T>P | No |
ClinGen Ensembl |
|
|
CA7218452 rs140807440 |
114 | E>G | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs1472137558 CA390110797 |
118 | M>T | No |
ClinGen TOPMed |
|
| TCGA novel | 121 | C>F | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA390110741 rs1311149860 |
123 | I>T | No |
ClinGen Ensembl |
|
|
rs866115201 CA262455356 |
125 | R>K | No |
ClinGen Ensembl |
|
|
CA390110679 rs1422095788 |
132 | S>N | No |
ClinGen gnomAD |
|
|
rs768572945 CA7218420 |
133 | N>S | No |
ClinGen ExAC gnomAD |
|
|
rs1477585762 CA390110624 |
139 | E>D | No |
ClinGen gnomAD |
|
|
CA390110501 rs1177867935 |
155 | Y>C | No |
ClinGen gnomAD |
|
| TCGA novel | 156 | E>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA390110478 rs1471092368 |
158 | F>S | No |
ClinGen gnomAD |
|
|
CA390110463 rs1197977354 |
160 | R>Q | Variant assessed as Somatic; 4.627e-05 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
|
CA390110459 rs1313412531 |
161 | F>V | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
| TCGA novel | 162 | L>W | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA390110435 rs1264837726 |
164 | S>N | No |
ClinGen gnomAD |
|
|
rs935647997 CA262454562 |
166 | E>G | No |
ClinGen TOPMed |
|
|
rs764926589 CA7218404 |
169 | P>T | No |
ClinGen ExAC gnomAD |
|
|
CA262454561 rs926961157 |
171 | I>T | No |
ClinGen TOPMed gnomAD |
|
| TCGA novel | 174 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA262454560 rs989854341 |
175 | Y>C | No |
ClinGen TOPMed |
|
| rs1376119775 | 175 | Y>I | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA262454558 rs979994932 |
176 | I>V | No |
ClinGen TOPMed |
|
|
CA7218403 rs776446375 |
177 | D>E | No |
ClinGen ExAC gnomAD |
|
|
rs763945045 CA7218383 |
198 | Y>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1312867741 CA390110148 |
203 | L>V | No |
ClinGen TOPMed |
|
|
CA7218380 rs771927271 |
204 | H>Y | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 207 | Y>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 215 | A>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1221708697 CA390110059 |
216 | F>L | No |
ClinGen TOPMed |
|
| TCGA novel | 218 | R>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs200722873 CA262452475 |
223 | N>S | No |
ClinGen 1000Genomes gnomAD |
|
| TCGA novel | 227 | R>= | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA390109958 rs1361660690 |
228 | F>Y | No |
ClinGen TOPMed |
|
|
CA390109916 rs1213230498 |
234 | H>Y | No |
ClinGen TOPMed |
|
|
rs778623597 CA7218345 |
236 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs949723341 CA262452224 |
250 | N>S | No |
ClinGen Ensembl |
|
| TCGA novel | 255 | P>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA262452220 rs919105059 |
262 | Q>* | No |
ClinGen TOPMed |
|
|
rs765520957 CA7218333 |
263 | F>L | No |
ClinGen ExAC gnomAD |
|
|
rs1351478162 CA390109014 |
265 | V>L | No |
ClinGen gnomAD |
|
|
CA390108982 rs1237782576 |
269 | I>M | No |
ClinGen gnomAD |
|
|
rs1285733607 CA390108974 |
271 | L>V | No |
ClinGen TOPMed |
|
|
rs1395844536 CA390108966 |
272 | H>Y | No |
ClinGen Ensembl |
|
| TCGA novel | 275 | R>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA390108940 rs1213935296 |
276 | S>G | No |
ClinGen TOPMed |
|
|
CA390108938 rs1270220161 |
276 | S>N | No |
ClinGen TOPMed |
|
|
CA390108918 rs1333073416 |
279 | L>F | No |
ClinGen TOPMed gnomAD |
|
|
CA262452218 rs972109757 |
279 | L>R | No |
ClinGen TOPMed |
|
|
rs1191828179 CA390108866 |
285 | A>S | No |
ClinGen gnomAD |
|
| TCGA novel | 286 | Y>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA390108841 rs1566669270 |
288 | I>M | No |
ClinGen Ensembl |
|
| TCGA novel | 288 | I>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
COSM3386619 CA7218310 rs761151881 |
288 | I>V | pancreas [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
|
CA7218309 rs368179547 |
289 | V>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA390108808 rs1313692823 |
293 | E>D | No |
ClinGen TOPMed |
|
|
rs772679993 CA390108789 |
296 | P>A | No |
ClinGen ExAC gnomAD |
|
|
rs1566669242 CA390108787 |
296 | P>R | No |
ClinGen Ensembl |
|
|
rs772679993 CA7218308 |
296 | P>S | No |
ClinGen ExAC gnomAD |
|
|
rs1275882867 CA390108772 |
299 | T>A | No |
ClinGen gnomAD |
|
|
rs1012484270 CA262452013 |
301 | P>L | No |
ClinGen Ensembl |
|
|
CA390108759 rs1217698623 |
301 | P>T | No |
ClinGen gnomAD |
|
| TCGA novel | 302 | V>A | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1566669111 CA390108735 |
303 | I>V | No |
ClinGen Ensembl |
|
|
CA390108591 rs1446463144 |
320 | M>I | No |
ClinGen gnomAD |
|
|
rs1304794357 CA390108533 |
328 | I>M | No |
ClinGen gnomAD |
|
|
CA7218286 rs771407076 |
331 | V>E | No |
ClinGen ExAC gnomAD |
|
|
CA390108437 rs1260712831 |
342 | E>G | No |
ClinGen TOPMed |
|
|
CA7218280 rs771776472 |
349 | A>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA390108357 rs1263207190 |
353 | S>C | No |
ClinGen TOPMed gnomAD |
|
|
CA390108356 rs1263207190 |
353 | S>F | No |
ClinGen TOPMed gnomAD |
|
|
CA390108342 rs1399716150 |
355 | P>H | No |
ClinGen TOPMed |
|
|
CA390108346 rs1425483367 |
355 | P>S | No |
ClinGen TOPMed |
|
|
rs771713749 CA7218260 |
360 | A>E | No |
ClinGen ExAC |
|
|
rs775008339 CA7218261 |
360 | A>T | No |
ClinGen ExAC gnomAD |
|
|
rs745671841 CA7218258 |
363 | A>S | No |
ClinGen ExAC gnomAD |
|
|
CA7218254 rs778053464 |
376 | I>T | No |
ClinGen ExAC gnomAD |
|
|
CA262451174 rs950547340 COSM1300730 |
380 | S>C | Variant assessed as Somatic; impact. urinary_tract [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated Ensembl NCI-TCGA |
|
CA7218250 rs61732995 |
381 | N>K | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA7218251 rs781304785 |
381 | N>S | No |
ClinGen ExAC gnomAD |
|
|
CA7218248 rs61756433 |
382 | V>I | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA7218247 rs374189416 |
389 | S>C | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA7218246 rs750917234 |
396 | K>E | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 399 | W>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA7218244 rs760132062 |
400 | N>S | No |
ClinGen ExAC gnomAD |
|
|
rs775015888 CA7218243 |
401 | P>L | No |
ClinGen ExAC gnomAD |
|
|
CA390107131 rs1334386552 |
403 | I>V | No |
ClinGen gnomAD |
|
|
CA7218221 COSM1221811 rs759166639 |
405 | A>V | large_intestine [Cosmic] | No |
ClinGen cosmic curated ExAC gnomAD |
|
rs773096948 CA7218217 |
413 | A>T | No |
ClinGen ExAC gnomAD |
|
|
CA390106971 rs1566662303 |
415 | M>V | No |
ClinGen Ensembl |
|
|
rs1161019914 CA390106949 |
416 | E>A | No |
ClinGen gnomAD |
|
|
CA262450921 rs1018169045 |
419 | S>N | No |
ClinGen Ensembl |
|
|
rs142027245 CA7218216 |
420 | T>A | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA262450919 rs1012030269 |
421 | M>I | No |
ClinGen TOPMed |
|
|
rs1023770547 CA262450920 |
421 | M>L | No |
ClinGen TOPMed |
|
|
rs776642897 CA7218215 |
423 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA390106872 rs1444354743 |
424 | E>K | No |
ClinGen gnomAD |
|
|
CA7218210 rs138474600 |
433 | R>C | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1214433807 CA390106807 |
433 | R>H | No |
ClinGen gnomAD |
|
|
rs138474600 CA390106810 |
433 | R>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
| TCGA novel | 434 | Q>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 435 | R>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 435 | R>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA390106762 rs1326388002 |
437 | K>R | No |
ClinGen gnomAD |
|
|
CA7218190 rs768412393 |
438 | K>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA390106744 rs1179039658 |
439 | K>N | No |
ClinGen TOPMed |
|
|
CA7218189 rs146316789 |
440 | E>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
| TCGA novel | 443 | R>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs550344803 CA262450200 |
449 | K>E | No |
ClinGen Ensembl |
|
| TCGA novel | 449 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1384955396 CA390106648 |
452 | D>G | No |
ClinGen TOPMed |
|
|
rs1184880844 CA390106652 |
452 | D>Y | No |
ClinGen gnomAD |
|
|
rs774751561 CA7218185 |
455 | L>V | No |
ClinGen ExAC gnomAD |
|
|
CA7218182 rs201561330 |
461 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs201561330 CA7218183 |
461 | R>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs746570920 CA7218180 |
461 | R>H | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs746570920 CA7218181 |
461 | R>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA390106525 rs1566658242 |
465 | I>V | No |
ClinGen Ensembl |
|
|
CA7218178 rs758191720 |
466 | P>S | No |
ClinGen ExAC gnomAD |
No associated diseases with Q16537
No regional properties for Q16537
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q16537 | |||
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| protein phosphatase type 2A complex | A protein complex that has protein serine/threonine phosphatase activity that is polycation-stimulated (PCS), being directly stimulated by protamine, polylysine, or histone H1; it constitutes a subclass of several enzymes activated by different histones and polylysine, and consists of catalytic, scaffolding, and regulatory subunits. The catalytic and scaffolding subunits form the core enzyme, and the holoenzyme also includes the regulatory subunit. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| protein phosphatase activator activity | Binds to and increases the activity of a protein phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a protein substrate molecule. |
| protein phosphatase regulator activity | Binds to and modulates the activity of a protein phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a protein substrate molecule. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| protein dephosphorylation | The process of removing one or more phosphoric residues from a protein. |
| signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
13 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| A4FV68 | PPP2R5E | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform | Bos taurus (Bovine) | PR |
| Q15172 | PPP2R5A | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform | Homo sapiens (Human) | PR |
| Q15173 | PPP2R5B | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform | Homo sapiens (Human) | PR |
| Q14738 | PPP2R5D | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform | Homo sapiens (Human) | PR |
| Q6PD03 | Ppp2r5a | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform | Mus musculus (Mouse) | PR |
| Q61151 | Ppp2r5e | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform | Mus musculus (Mouse) | PR |
| O04375 | B'ALPHA | Serine/threonine protein phosphatase 2A 57 kDa regulatory subunit B' alpha isoform | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q93YV6 | B'KAPPA | Serine/threonine protein phosphatase 2A 57 kDa regulatory subunit B' kappa isoform | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q8LF36 | B'THETA | Serine/threonine protein phosphatase 2A 57 kDa regulatory subunit B' theta isoform | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9ZQY6 | B'DELTA | Serine/threonine protein phosphatase 2A 55 kDa regulatory subunit B' delta isoform | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9LVE2 | B'ZETA | Serine/threonine protein phosphatase 2A 59 kDa regulatory subunit B' zeta isoform | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q8RW96 | B'GAMMA | Serine/threonine protein phosphatase 2A 59 kDa regulatory subunit B' gamma isoform | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9LU89 | B'ETA | Serine/threonine protein phosphatase 2A 59 kDa regulatory subunit B' eta isoform | Arabidopsis thaliana (Mouse-ear cress) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSSAPTTPPS | VDKVDGFSRK | SVRKARQKRS | QSSSQFRSQG | KPIELTPLPL | LKDVPSSEQP |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ELFLKKLQQC | CVIFDFMDTL | SDLKMKEYKR | STLNELVDYI | TISRGCLTEQ | TYPEVVRMVS |
| 130 | 140 | 150 | 160 | 170 | 180 |
| CNIFRTLPPS | DSNEFDPEED | EPTLEASWPH | LQLVYEFFIR | FLESQEFQPS | IAKKYIDQKF |
| 190 | 200 | 210 | 220 | 230 | 240 |
| VLQLLELFDS | EDPRERDYLK | TVLHRIYGKF | LGLRAFIRKQ | INNIFLRFVY | ETEHFNGVAE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| LLEILGSIIN | GFALPLKAEH | KQFLVKVLIP | LHTVRSLSLF | HAQLAYCIVQ | FLEKDPSLTE |
| 310 | 320 | 330 | 340 | 350 | 360 |
| PVIRGLMKFW | PKTCSQKEVM | FLGELEEILD | VIEPSQFVKI | QEPLFKQIAK | CVSSPHFQVA |
| 370 | 380 | 390 | 400 | 410 | 420 |
| ERALYYWNNE | YIMSLIEENS | NVILPIMFSS | LYRISKEHWN | PAIVALVYNV | LKAFMEMNST |
| 430 | 440 | 450 | 460 | ||
| MFDELTATYK | SDRQREKKKE | KEREELWKKL | EDLELKRGLR | RDGIIPT |